ABCB5 and graft versus host disease: Furthermore, ABCB5+ MSCs can restrain ROS release from activated peripheral neutrophils [88] and might thus be able to alleviate ROS-mediated tissue damage by neutrophils recruited to the gastrointestinal tract during GvHD [196].